Literature DB >> 29749453

Identification of a VHL gene mutation in a Chinese family with Von Hippel‑Lindau syndrome.

Zhengwen He1, Lu Xia2, Zhiyong Deng1, Aojie Lian2, Zhengmao Hu2, Bin Li3.   

Abstract

Von Hippel‑Lindau (VHL) syndrome is an autosomal dominant neoplastic disorder. The VHL tumor suppressor (VHL) gene has previously been identified to represent the causative gene of VHL. Previous studies have demonstrated that >506 different mutations in VHL are associated with VHL syndrome. The aim of the present study was to determine the VHL gene mutation present in a VHL syndrome pedigree and to investigate the pathogenesis of the mutant protein. Briefly, a family suffering from VHL syndrome in a Chinese Han population was recruited, and a missense mutation (c.345 C>A: p.H115Q) was revealed to be present within the VHL gene in the proband. Furthermore, Sanger sequencing revealed two carriers of the mutation within the family. The results of the present study also demonstrated a mutation in VHL associated with the VHL syndrome phenotype, which may be of future therapeutic benefit for the diagnosis of VHL syndrome. These results may also be relevant to further studies aiming to investigate the molecular pathogenesis of VHL syndrome.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29749453     DOI: 10.3892/mmr.2018.8974

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  2 in total

1.  Von Hippel-Lindau "Black Forest" mutation inherited in a large Chinese family.

Authors:  Peihua Liu; Feizhou Zhu; Minghao Li; Daud Athanasius Dube; Qianqian Liu; Cikui Wang; Qiao Xiao; Liang Zhang; Shuai Gao; Zhuolin Li; Bo Zhang; Jing Liu; Longfei Liu; Xiang Chen
Journal:  Gland Surg       Date:  2019-08

2.  Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype-phenotype correlation and gene therapy perspective.

Authors:  Dali Tong; Yao Zhang; Jun Jiang; Gang Bi
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.